Navigation Links
Align Technology Announces Fourth Quarter and Fiscal 2008 Results
Date:1/28/2009

SANTA CLARA, Calif., Jan. 28 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN) today reported financial results for the fourth quarter and fiscal year ended December 31, 2008.

Total net revenues for the fourth quarter of fiscal 2008 (Q4 08) were $74.1 million compared to $72.5 million reported in the fourth quarter of 2007 (Q4 07) and compared to $75.2 million reported in the third quarter of 2008 (Q3 08). For fiscal 2008 (FY 08), net revenues of $304.0 million increased 6.9 percent from $284.3 million reported for fiscal 2007 (FY 07).

"Despite the challenges of fiscal 2008 we had many significant accomplishments," said Thomas M. Prescott, president and CEO of Align Technology. "We successfully launched three new products including Invisalign Teen, grew annual revenues during the worst business environment in decades, and took action to reduce the Company's cost structure. As we embark on a new year, the economy remains very difficult and our outlook is more uncertain. However, the market opportunity and value proposition for Invisalign is strong and we will continue to execute our strategy to drive adoption worldwide."

Net profit for Q4 08 was $65.5 million, or $0.98 per diluted share. This includes a restructuring charge of $4.0 million and a favorable impact of approximately $64.6 million, or $0.97 per diluted share from the release of a tax valuation allowance on specific deferred tax assets. This is compared to net profit of $5.7 million, or $0.08 per diluted share in Q4 07, and net profit of $5.2 million, or $0.08 per diluted share in Q3 08. Stock-based compensation expense included in Q4 08 net profit was $3.9 million compared to $3.4 million in Q4 07, and $4.4 million in Q3 08.

Net profit for fiscal 2008 was $80.0 million, or $1.18 per diluted share, which in
'/>"/>

SOURCE Align Technology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. MedPredict Publishes Two New Reports Providing Expert Analysis of Malignant Hematology Drug Development
2. A Stage IV Malignant Melanoma Drug That Increases Overall Survival Would Earn a Higher Patient Share in the U.S. Than in Europe
3. Tennessee Hospital Association Selects PivotHealth To Provide Hospital-Physician Alignment Services
4. FDA Clears Expanded Labeling for the Invisalign System
5. Align Technology to Announce Fourth Quarter and Fiscal Year 2008 Results on January 28, 2009
6. Cardo Medical Announces FDA Clearance of the Align 360 Total Knee System
7. Align Technology Announces Third Quarter Fiscal 2008 Results
8. 5- and 10-year survival continues to improve for US children with hematologic malignancies
9. SpectraScience Awarded Patent for Correcting Image Misalignment
10. Align Technology Announces Second Quarter Fiscal 2008 Results
11. Align Technology Targets Mainstream Orthodontics Market With Invisalign Teen(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , ... July 06, 2015 , ... ... pre-clinical stages of drug discovery. iPSCs are generated from adult cells, such as ... any cell type in the human body. , iPSC-derived cardiomyocytes ...
(Date:7/6/2015)... ... 2015 , ... “ TapGlance ” was featured on NewsWatch as part of ... the market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and ... app helps users visualize what rooms will look like before they even start renovating.. ...
(Date:7/6/2015)... ... July 06, 2015 , ... On June 22, 2015, Fox News in a report titled “ Female Hair Loss ... turn age 35 a quarter of all women in the U.S. will suffer from thinning ... stigmatized and rarely discussed. One woman, a former beauty queen, who was interviewed for the ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... or midwives, yet there is a large gap between the unmet health priorities ... to improve health outcomes and reduce unnecessary or ineffective treatments or procedures. , ...
(Date:7/6/2015)... ... 2015 , ... Olive Fertility Centre is proud to announce that Olive medical ... behalf of the department of Family Practice. , “This award is a real honour,” ... The technology is changing so rapidly and we are also developing new models of ...
Breaking Medicine News(10 mins):Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:Olive Fertility Centre Physician Honoured for Teaching 2
... News) -- While a tetanus shot can shield Americans from ... those who went unvaccinated, the U.S. Centers for Disease Control ... potentially deadly disease caused by the toxin of Clostridium ... excrement. Since 1947, reported cases of tetanus in the United ...
... 31 March, 2011 - There is growing evidence ... the lifespan. The risk factors for ... studied because this life phase is associated with ... risk during adolescence include pleasure-seeking, behavioral disinhibition, and ...
... of the AKIN criteria (Acute Kidney Injury Network) in ... to change future diagnosis, according to results from a ... Congress. As screening and differential diagnosis is becoming increasingly ... these results are confirmed in larger studies, the AKIN ...
... Speaking at the UK National Stem Cell Network conference ... from the University of Glasgow will discuss a brand ... which a small number of cancer cells persist despite ... type of blood cancer caused by the infamous "Philadelphia ...
... HealthDay Reporter , WEDNESDAY, March 30 (HealthDay News) -- An ... (FDA) is meeting Wednesday and Thursday to see if ... disorder (ADHD), and if so, what should be done. ... watchdog groups and academics who,ve long agitated for a closer ...
... (HealthDay News)-- Liver transplant patients who quit smoking are ... suggests. Spanish researchers reviewed data from hundreds of ... 1990 and December 2009. Over the average follow-up period ... transplant had a lower incidence of smoking-related cancers than ...
Cached Medicine News:Health News:Tetanus Still Diagnosed in U.S., Although It's Preventable 2Health News:Different genes influence smoking risk during adolescence and adulthood 2Health News:Results show benefits in using acute kidney injury criteria in the diagnosis of cirrhosis 2Health News:New approach to leukemia chemotherapy -- is a cure in sight? 2Health News:FDA Panel Examines Possible Links Between Food Dyes, ADHD 2Health News:FDA Panel Examines Possible Links Between Food Dyes, ADHD 3Health News:FDA Panel Examines Possible Links Between Food Dyes, ADHD 4Health News:Quitting Smoking Cuts Cancer Risk After Liver Transplant 2
(Date:7/6/2015)... N.J. , July 6, 2015 ... on developing novel therapeutics that target inflammation and ... Bradford , M.D., PhD, as Chief Medical Officer. ... company,s clinical development strategy and programs, which include ... other inflammatory and fibrotic conditions.  Bill is an ...
(Date:7/6/2015)... July 6, 2015   Cepheid (Nasdaq: CPHD ... for its 2015 second quarter ended June 30, 2015 ... the market. The Company will host a ... July 23, 2015, to discuss the results.  To access ... http://ir.cepheid.com at least 15 minutes before the scheduled ...
(Date:7/6/2015)... 2015 China Information Technology, Inc. (the "Company" ... integrated cloud-based platform, exchange, and big data solutions in ... Company launched its mobile app for Healthcare One Pass, ... on mobile devices. The Company jointly hosted the launch ... Bureau and Shenzhen News Net.   The mobile ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4
... MBA is a complete practice and ... for optometrists, opticians and ophthalmologists- It ... users seeking a graphically rich and ... complement of solid features and functionality- ...
... 120 hematology system is ... workflow and achieve long-term ... offers a unique portfolio ... the needs of clinicians, ...
The Advia 60 is designed to deliver powerful performance in a small package....
The SF-3000 automated hematology analyzer can provide accurate and precise 23-parameter hematolgy results including a fully automated WBC 5-part differential from a compact space-save design....
Medicine Products: